# Fulvestrant

NDC: 0143-9022
Generic name: Fulvestrant
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR
Marketing started: 20220210

FDA application: ANDA214682

## Active ingredients

- FULVESTRANT: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0143-9022"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0143-9022
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=306c283b-9abe-4985-856b-1957f1f3af8b